High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study. [electronic resource]
Producer: 20020308Description: 1363-72 p. digitalISSN:- 0008-543X
- Adult
- Antibodies -- chemistry
- Antigens, CD20 -- immunology
- Antineoplastic Agents -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunoconjugates -- administration & dosage
- Iodine Radioisotopes -- administration & dosage
- Lymphoma, Mantle-Cell -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Pilot Projects
- Radioimmunotherapy
- Radiometry
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.